View Annual Report - Jules Stein Eye Institute
View Annual Report - Jules Stein Eye Institute
View Annual Report - Jules Stein Eye Institute
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
steven Nusinowitz, PhD<br />
Associate Professor of Ophthalmology<br />
Co-Director of the Visual Physiology Laboratory<br />
Director of the Live Imaging and<br />
Functional Evaluation (LIFE) Core<br />
Member of the <strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong><br />
ReseaRch summaRy<br />
Mechanisms of Retinal Degeneration<br />
Dr. Nusinowitz’s primary research interest is focused on<br />
understanding the cellular contributions to noninvasive<br />
measures of visual function and defining the sites and<br />
mechanisms of disease action in inherited retinal and<br />
visual pathway disorders. His main approach to gaining<br />
an understanding of the site and underlying mechanism<br />
of disease action in humans is to study the patterns of<br />
electrophysiological and psychophysical responses<br />
obtained from mice in which the disruption of different<br />
cells or pathways in the visual system are specifically<br />
targeted by genetic manipulation. By comparing the<br />
patterns of responses in human disease with the<br />
patterns of responses from rodents with targeted<br />
cellular disruption, Dr. Nusinowitz is able to test hypotheses<br />
about the underlying pathophysiology in human<br />
disease and to provide a mechanism for the development<br />
of specific diagnostic tools that are sufficiently<br />
sensitive for early detection and better diagnosis of<br />
clinical disease.<br />
Public Service<br />
Editorial Board Service, Current <strong>Eye</strong> Research and<br />
Investigative Ophthalmology and Visual Science<br />
Grant Reviewer, Foundation Fighting Blindness and<br />
Medical Research Council of Canada<br />
Scientific Advisor: The Mouse Mutant Resource,<br />
The Jackson Laboratory; Novartis Pharmaceuticals;<br />
Allergan, Inc.; and Revision Therapeutics, Inc.<br />
Reviewer for many scientific journals<br />
Research Grants<br />
California <strong>Institute</strong> for Regenerative Medicine:<br />
Development of a Stem Cell-Based Transplantation Strategy<br />
for Treating Age-Related Macular Degeneration (Principal<br />
Investigator: Gabriel H. Travis, MD, with other investigators),<br />
11/1/09–10/31/12<br />
National <strong>Institute</strong>s of Health/National <strong>Eye</strong> <strong>Institute</strong>:<br />
<strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong> Core Grant for Vision Research,<br />
for shared-use core facilities among investigators at<br />
the <strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong> (Module Co-Director),<br />
3/1/10–2/28/15<br />
UCLA/Foundation Fighting Blindness Center Grant:<br />
Module I: Clinical Characterization and Correlation With<br />
Molecular Genetic Studies of Individuals With Suspected<br />
Stargardt Disease (Co-Investigator), 7/1/10–6/30/13<br />
Research to Prevent Blindness (Unrestricted Department<br />
Grant): Characterizing Visual Function in HIV-infected<br />
Patients (Principal Investigator), 4/25/11–4/1/12<br />
Faculty | Nusinowitz 57